Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor-beta 1.

Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress KE, Brattain DE, Brattain MG.

Exp Cell Res. 1989 Apr;181(2):442-53.

PMID:
2538337
2.

Promotion of differentiation in human colon carcinoma cells by vasoactive intestinal polypeptide.

Hoosein NM, Black BE, Brattain DE, Brattain MG.

Regul Pept. 1989 Jan;24(1):15-26.

PMID:
2544928
3.

Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.

Mulder KM, Ramey MK, Hoosein NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG.

Cancer Res. 1988 Dec 15;48(24 Pt 1):7120-5.

PMID:
3191488
4.

Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines.

Wan CW, McKnight MK, Brattain DE, Brattain MG, Yeoman LC.

Cancer Lett. 1988 Dec 1;43(1-2):139-43.

PMID:
3264518
5.

Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line.

Hoosein NM, Brattain DE, McKnight MK, Childress KE, Chakrabarty S, Brattain MG.

Cancer Lett. 1988 Jun 15;40(2):219-32.

PMID:
3164250
6.

Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose.

Boyd DD, Levine AE, Brattain DE, McKnight MK, Brattain MG.

Cancer Res. 1988 May 1;48(9):2469-74.

7.
8.

Modulation of c-myc by transforming growth factor-beta in human colon carcinoma cells.

Mulder KM, Levine AE, Hernandez X, McKnight MK, Brattain DE, Brattain MG.

Biochem Biophys Res Commun. 1988 Jan 29;150(2):711-6.

PMID:
2893611
9.

Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.

Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG.

Cancer Res. 1987 Jun 1;47(11):2950-4.

10.

Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.

Willson JK, Long BH, Chakrabarty S, Brattain DE, Brattain MG.

Cancer Res. 1985 Nov;45(11 Pt 1):5281-6.

11.

Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line.

Levine AE, McRae LJ, Hamilton DA, Brattain DE, Yeoman LC, Brattain MG.

Cancer Res. 1985 May;45(5):2248-54.

12.

Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.

Willson JK, Long BH, Marks ME, Brattain DE, Wiley JE, Brattain MG.

Cancer Res. 1984 Dec;44(12 Pt 1):5880-5.

13.

Effects of mitomycin on human colon carcinoma cells.

Long BH, Willson JK, Brattain DE, Musial S, Brattain MG.

J Natl Cancer Inst. 1984 Oct;73(4):787-92.

PMID:
6434780
14.

Characterization of human colon carcinoma cell lines isolated from a single primary tumour.

Brattain MG, Marks ME, McCombs J, Finely W, Brattain DE.

Br J Cancer. 1983 Mar;47(3):373-81.

15.

Enhancement of growth of human colon tumor cell lines by feeder layers of murine fibroblasts.

Brattain MG, Brattain DE, Sarrif AM, McRae LJ, Fine WD, Hawkins JG.

J Natl Cancer Inst. 1982 Oct;69(4):767-71.

PMID:
6956756
16.

Heterogeneity of malignant cells from a human colonic carcinoma.

Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE.

Cancer Res. 1981 May;41(5):1751-6.

17.

Initiation and characterization of cultures of human colonic carcinoma with different biological characteristics utilizing feeder layers of confluent fibroblasts.

Brattain MG, Brattain DE, Fine WD, Khaled FM, Marks ME, Kimball PM, Arcolano LA, Danbury BH.

Oncodev Biol Med. 1981;2(5):355-66.

PMID:
7329817

Supplemental Content

Loading ...
Support Center